SMAD4 and pancreatic neoplasm: Interestingly, while the α1β1 integrin is only expressed in cell lines containing SMAD4 mutations, the function-blocking monoclonal antibody against α1 had no effect on pancreatic cancer cell adhesion or migration on type I collagen either alone or in combination with the α2 function-blocking monoclonal antibody.